The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Transaction Update

1 Feb 2022 07:00

RNS Number : 2269A
Path Investments plc
01 February 2022
 

1 February 2022

Path Investments plc("Path" or the "Company")

Proposed Transaction Update

 

Path Investments plc (TIDM: PATH), is pleased to provide an update following the Company's announcements on 13 August and 31 December 2021 that the Company had entered into a conditional sale and purchase agreement (the "Agreement") to acquire the entire issued share capital of DG Innovate Ltd ("DG Innovate") (the "Proposed Transaction").

Long Stop Date Extension

As previously announced, the Proposed Transaction is subject, inter alia, to the approval of Path's independent shareholders and waiver of Rule 9 of the Takeover Code by the Takeover Panel, together with the publication of a prospectus and the application by the Company to have its enlarged share capital listed on the Standard Segment of the Official List and admitted to trading on the Main Market of the London Stock Exchange. Path and its advisers are making very good progress with the Proposed Transaction, including on the process of seeking approval of the FCA for the prospectus, and in order to allow time to conclude matters, including convening the required General Meeting of Path shareholders, it has now been agreed with DG Innovate to extend the long stop date for the satisfaction of all conditions to 31 March 2022.

Increased Secured Loan Facility

As part of the Proposed Transaction, as previously announced on 13 August and 22 September 2021, Path has provided a secured loan to DG Innovate of £600,000. In view of the extended long stop date, it has been agreed with DG Innovate to increase the secured loan facility by up to a further £450,000 (the "Increased Facility"). £150,000 of the Increased Facility has been provided to DG Innovate today and it may draw down a further £150,000 one calendar month from today's date and a further £150,000 two calendar months from today's date (subject to the posting of the Company's prospectus to shareholders by 28 February 2022).

Amendment to the Terms of the Proposed Transaction

As announced on 13 August 2021, Path has entered into the Agreement to acquire DG Innovate for £32 million to be satisfied by the issue of 5,342,051,305 Path Ordinary Shares of £0.001 each ("Path Shares") at an issue price of 0.6 pence per Path Share. The Agreement has now been amended to provide for further conditional deferred consideration of £5.373 million to be satisfied by the issue of 895,610,844 Path Shares on the first anniversary of completion should DG Innovate sign at least two multi-year supply agreements for the provision of their motor technology with certain defined customers prior to this date.

Further announcements will be made in due course, as appropriate. In the meantime, Path's shares will remain suspended from trading on the London Stock Exchange.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

Jack Allardyce

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Samantha Harrison

Harrison Clarke

Daphne Zhang

020 7383 5100

 

ETX Capital (Broker)

020 7392 1400

Tom Curran

Thomas Smith

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDMZGFMLMRGZZM
Date   Source Headline
28th Apr 20172:29 pmRNSNotice of AGM, Posting of Accounts & Board Changes
27th Apr 20177:00 amRNSAnnual results for the year ended 31 December 2016
13th Apr 20172:45 pmRNSHolding(s) in Company
30th Mar 20177:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.